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bstract
A series of 34 substituted purine analogues derivatives were subjected to quantitative structure-activity relationship analyses
s inhibitors of c-Src tyrosine kinase. Partial least squares regression was applied to derive QSAR models, which were further
alidated for statistical significance by internal and external validation. The best QSAR model developed had a good predictive
orrelation coefficient (r2) of 0.8319, a significant cross-validated correlation coefficient (q2) of 0.7550, and an r2 for the external
est set (pred r2) of 0.7983. It was developed from the PLS method with descriptors including the SsCH3E-index, H-Donor Count,
 2 Cl 3, and negative correlation with SsOHcount. The current study provides better insight into the future design of more potent
-Src tyrosine kinase inhibitors prior to synthesis.
 2015 The Author. Production and hosting by Elsevier B.V. on behalf of Taibah University. This is an open access article under
he CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Protein tyrosine kinases are enzymes that catalyze
he transfer of the terminal ATP phosphate to spe-
ific tyrosine residues present on a target substrate
1]. Protein tyrosine kinases regulate signalling path-
ays for a broad spectrum of cellular processes,
ncluding responses to growth factors, neurotransmitters∗ Tel.: +91 9826372944.
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the regulation of cell-cell and cell-extracellular matrix
interactions, as well as development, oncogenesis, and
angiogenesis [2,3]. The protein c-Src kinase is a
nonreceptor tyrosine kinase that acts as a signal transduc-
tion inhibitor and is a critical component of multiple sig-
nalling pathways controlling cell growth, proliferation,
invasion, and apoptosis. While c-Src kinase is highly
regulated and active only at low levels in most normal
cells, studies have shown its upregulation in many human
tumour types [4,5]. Protein tyrosine kinases (PTKs) are
enzymes responsible for the phosphorylation of other
proteins and can catalyze the transfer of the -phosphateehalf of Taibah University. This is an open access article under the
group of ATP to protein phenolic groups (on Tyr). PTKs
play a central role in signal transduction pathways and
are involved in the immune, endocrine, and nervous sys-
tem physiology and pathology [6]. The enzyme c-Src
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tyrosine kinase plays versatile roles in cell responses
induced by platelet-derived growth factor (PDGF),
including cell growth, cell cycle progression, cell sur-
vival, cell migration, actin cytoskeleton rearrangement,
DNA synthesis and receptor endocytosis [7,2]. Src
kinases play crucial roles in signal transduction pathways
and in regulating various cellular functions such as cell
proliferation and cell differentiation [8]. The activity and
structural conformation of the Src-family protein kinases
are mainly regulated by phosphorylation events [9]. Src
kinase is a protooncogenic tyrosine kinase [10] and has
been implicated in the genesis and progression of multi-
ple types of human cancer, including colon, breast, lung,
and other cancers [11]. Quantitative structure–activity
relationships (QSARs) are an attempt to correlate the
structural or property descriptors of compounds quan-
titatively with biological activities. The traditional 2D-
QSAR model is only a rough approximation of the real
relationships, as it mainly uses molecular descriptors.
QSAR models, mathematical equations relating chemi-
cal structure to biological activity, provide useful infor-
mation for drug design and medicinal chemistry [12].
Quantitative structure–activity relationships (QSARs)
help to predict the biological activity of new structures
and may reveal useful information on structural modifi-
cation at several substitutional positions of c-Src-binding
molecules [13–16]. This work was undertaken to find
a correlation between physicochemical parameters and
the biological activity of a series of novel purine deriva-
tives as c-Src tyrosine kinase analogues. This paper is
an attempt at a predictive technique based on partial
least squares regression, which identifies key struc-
tural features responsible for governing c-Src tyrosine
kinase.
2.  Materials  and  method
2.1.  Computational  method
Computational studies were performed on an HP with
Windows 7 Home Basic running on an Intel® core pro-
cessor. The molecular structures of the compounds in the
data set were sketched using the V-life MDS (Molec-
ular Design Suite)TM 3.5 software supplied by V-life
Sciences Technologies [17]. Analogues of purine deriva-
tives reported to have potent and selective inhibitory
activity against c-Src tyrosine kinase were taken from
the literature [18]. The biological assay used to test the
activity of all of the molecules was the same, and hence,
the inhibition values indicated by IC50 are comparable.
The biological activities represented by IC50 were con-
verted into the corresponding pIC50 values (−log IC50),ity for Science 10 (2016) 563–570
which were used as dependent variables in the QSAR
analysis. For this study, a total of 34 purine derivatives
were divided into training and test sets consisting of
twenty-six and eight compounds (Table 1), respectively.
The sphere exclusion method [19] was adopted to
divide the training and test data set comprising of
twenty-six and eight compounds, respectively, with a
dissimilarity value of 8.6, where the dissimilarity value
gives the sphere exclusion radius. This algorithm allows
the construction of training sets covering all descrip-
tor space areas occupied by representative points. Eight
compounds, namely 3, 6, 8, 10, 19, 23, 27 and 31, were
used as the test set, while the remaining molecules were
used as the training set. Initially, the data set was split
into training (70%) and test sets (30%) using the MDS
software. Care was taken to achieve an even distribution
of activities in both sets (training and test).
To perform the QSAR analysis, the structures of
the compounds in the data set were sketched, and the
physicochemical descriptors of the molecules were cal-
culated using the V-life MDS (molecular design suite)
software. All of the compounds were batch optimized
to minimize energies and optimize the geometry using
Merck molecular force fields, followed by considering
the distance-dependent dielectric constant of 1.0, the
convergence criterion or root mean square (RMS) gradi-
ent of 0.01 kcal/mol A˚ and the iteration limit of 10,000
[20].
2.2.  Two-dimensional  QSAR
A large number of theoretical descriptors, such as SA
Most Hydrophilic (most hydrophilic value on the vdW
surface), SA Most Hydrophobic–Hydrophilic Distance
(distance between most hydrophobic and hydrophilic
point on the vdW surface), SA Hydrophilic Area (vdW
surface descriptor showing hydrophilic surface area) and
SK Most Hydrophilic, the radius of gyration, Wiener’s
index, moment of inertia, semi-empirical descriptors,
HUMOEnergy (highest occupied molecular orbital),
heat of formation and ionization potential, as well as
constitutional, physicochemical, electrostatic, topologi-
cal and semi-empirical descriptors have been computed
from chemical structures with a view to developing
the structure-activity relationships of purine com-
pounds, which would, in turn, predict their biological
activity.The independent variables (i.e., descriptors) were pre-
processed by removing the invariable values (constant
column), which resulted in a total of 280 descriptors for
use in QSAR analysis. Descriptors with the same value
M.C. Sharma / Journal of Taibah University for Science 10 (2016) 563–570 565
Table 1
Structure, and biological activity of purine derivatives as c-Src tyrosine kinase.
N
N N
N
R3
R1
R2
Compounds 1-2
N
N NH
N
NH
N
Compounds 3-11
HN
R
N
N NH
N
NH
N
Compounds 12-23
O
R
N
N NH
N
NH
N
Compounds 24-34
N
R
OH
.
S. no Compound no. R1 = 1–2 and R = 3–34 R2 R3 IC50 pIC50 Set
1 NH2OMe HN N H 2.43 5.614 Training
2
NH2
HN N H 2.42 5.616 Training
3 3-Methoxy H H 1.21 5.917 Test
4 4-Chloro H H 1.18 5.928 Training
5 4-Bromo H H 1.76 5.754 Training
6 4-Nitro H H 1.4 5.853 Test
7 3-Nitro H H 0.95 6.022 Training
8 4-Aminosulfonyl H H 1.82 5.739 Test
9 3-Aminosulfonyl H H 0.1 7.000 Training
10 4-Carbamoyl H H 2.2 5.657 Test
11 4-Acetamido H H 1.05 5.978 Training
12 H H H 0.75 6.124 Training
13 4-Methoxy H H 0.13 6.886 Training
14 3-Methoxy H H 0.93 6.031 Training
15 3-Methyl H H 0.83 6.08 Training
16 4-Chloro H H 0.34 6.468 Training
17 4-Bromo H H 0.45 6.346 Training
18 4-Nitro H H 0.39 6.408 Training
19 3-Nitro H H 0.13 6.886 Test
20 4-Aminosulfonyl H H 0.02 7.698 Training
21 3-Aminosulfonyl H H 0.12 6.92 Training
22 4-Carbamoyl H H 2.01 5.696 Training
23 4-Acetamido H H 0.65 6.187 Test
24 H H H 3.14 5.503 Training
25 4-Methoxy H H 1.33 5.876 Training
26 3-Methoxy H H 1.2 5.92 Training
27 3-Methyl H H 2.55 5.602 Test
28 4-Chloro H H 0.69 6.161 Training
29 4-Nitro H H 0.78 6.107 Training
30 3-Nitro H H 0.34 6.468 Training
31 4-Aminosulfonyl H H 0.26 6.585 Test
32 3-Aminosulfonyl H H 0.34 6.468 Training
33 4-Carbamoyl H H 1.22 5.913 Training
34 4-Acetamido H H 1.59 5.798 Training
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or almost the same value or that were highly correlated
with other descriptors were removed initially.
2.3.  Statistical  computation
To calculate q2, each molecule in the training set was
sequentially removed, the model refit using the same
descriptors, and the biological activity of the removed
molecule predicted using the refit model [21]. The value
of q2 was calculated using the following equation:
q2 =  1 −
∑ (yi −  yˆi)2
∑ (yi −  ymean)2
(1)
where yi, yˆi are the actual and predicted activity of the ith
molecule in the training set, respectively, and ymean is the
average activity of all molecules in the training set. For
external validation, the activity of each molecule in the
test set was predicted using the model generated from the
training set. The pred r2 value is calculated as follows
(Eq. (2)):
pred r2 =  1 −
∑ (yi −  yˆi)2
∑ (yi −  ymean)2
(2)
where yi, yˆi are the actual and predicted activity of the
ith molecule in the test set, respectively, and ymean is the
average activity of all molecules in the training set.
The developed quantitative model was evaluated
using the following statistical measures: N, number of
observations (molecules) in the training set; q2, cross-
validated r2 (by leave one out), which is a relative
measure of the quality of fit; pred r2, r2 for the exter-
nal test set; q2 se, standard error of cross-validation; and
pred r2 se, the standard error of the external test set pre-
diction. The low standard error of pred r2 se and q2 se
show the obsolete quality of fitness of the model. The
high pred r2 and low pred r2 se show the high predictive
ability of the model. The q2 and pred r2 values were used
as deciding factors in selecting the optimal models.
3.  Results  and  discussion
In this study, the training and test sets were generated
using the sphere selection method followed by the par-
tial least squares regression analysis. Several 2D QSAR
models were constructed, and the best three regression
equations obtained were as follows:
pIC50 =  1.2458(±0.1665) SsCH3E-index
− 0.5927(±0.0462) SsOHcount
+  0.6189(±0.0813) H-Donor Count
+  0.9188(±0.0651) T 2 Cl 3+0.3085ity for Science 10 (2016) 563–570
Degrees of Freedom = 24, Ntraining = 26, Ntest = 8,
r2 = 0.8319, q2 = 0.7550, F  test = 43.148, r2 se = 0.4572,
q2 se = 0.3588, pred r2 = 0.7983, pred r2se = 0.2432,
ZScore Qˆ2 = 1.971, Best Rand Qˆ2 = 0.58238.
QSAR model (1) can explain 79% of the variance in
the observed activity values. The r2 se has a low value for
the regression equation, indicating goodness of fit. The
major group of descriptors involved sub groups such as
the SsCH3E-index contribution descriptor, the hydrogen
donor count and SsOHcount that help in understand-
ing the effect of substituents at different positions of the
purine. An estate contribution descriptor, the SsCH3E-
index, which represents the electro-topological state for
the number of CH3 groups connected with single bonds,
is inversely proportional to the activity of the R1 posi-
tion, which may lead to an increase in the activity.
Molecules (compounds 15  and 27) with greater num-
bers of methyl groups have more potent activity towards
Src tyrosine kinase. The next contributing descriptor is
the SsOHcount estate number (∼16%), which represents
the total number of hydroxyl groups connected with
single bonds, showing that hydroxyl groups should be
directly attached to the purine ring for maximal activ-
ity. The alignment descriptor is T 2 Cl 3, which refers
to the count of the number of double bonds separated
from chlorine atoms by one bond distance in a molecule
and indicates that the activity increased with the pres-
ence of a chlorine R1 position on the purine moiety, as in
compounds 4, 16 and 28. The most strongly contributing
descriptor is the H-donor count, the number of hydrogen
bond donor atoms in a molecule, which is directly pro-
portional to the activity and suggests that an increase
in the H-donor count of the fragment’s R  position is
favourable for its activity. The contribution chart of
selected descriptors is shown in Fig. 1a, and plots of pre-
dicted vs.  observed values of pIC50 are shown in Fig. 1b.
The correlation matrix is shown in Table 2, demonstrat-
ing the good correlation of the selected parameters with
biological activity.
pIC50 =  −0.8753(±0.1641) Bromine count
+ 0.1764(±0.0863) SsClE-index
+  0.2724(±0.0451) mol.  wt.
Degrees of Freedom = 24, Ntraining = 26, Ntest = 8,
r2 = 0.7311, q2 = 0.6763, F  test = 36.416, r2 se = 0.4168,
q2 se = 0.3921, pred r2 = 0.7046, pred r2se = 0.5486,
ZScore Qˆ2 = 2.3657, Best Rand Qˆ2 = 1.7685.QSAR model-2 used the PLS analysis method
and was confirmed by the statistical measures viz.,
the squared correlation coefficient (r2), which meas-
ures how closely the observed data track the fitted
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Table 2
Correlation matrix between descriptors present in the best QSAR model-1.
Parameter SsCH3E-index H-Donor count T 2 Cl 3 SsOHcount
SsCH3E-index 1.0000
H-Donor count 0.3276 1.0000
T 2 Cl 3 0.2047 0.5287 1.0000
SsOHcount 0.4864 0.6188 0.8064 1.0000
c
e
t
b
b
S
r
F
vorrelation line, and the standard error (r2 se), which
xpresses the variation of the residuals or the varia-
ion about the regression line. QSAR model 2, obtained
y the PLS method, shows good correlation between
iological activity and the parameters Bromine count,
sClE-index, and mol. wt. The correlation coefficient
2
= 0.7311, and the model explains approximately
ig. 1. (a) Plot of contribution chart of 2D QSAR model. (b) Graphs of observ
s. predicted activity of 2D QSAR model-2. (d) Graphs of observed vs. predic73% of the variation in activity. The model was
subjected to cross validation, and the value of the cross-
validated squared correlation coefficient (q2 = 0.6763),
the low sum of squares (pred r2se = 0.5486) and
the ZScore Qˆ2 of predictivity suggested good pre-
dictive ability of the biological activity of diverse
structures.
ed vs. predicted activity of 2D QSAR model-1. (c) Graphs of observed
ted activity of 2D QSAR model-3.
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 (ContiFig. 1.
The descriptor SsClE-index represents the electro-
topological state indices for the number of chlorine
atoms connected with one single bond, and it suggests
that presence of chlorine atoms in the molecule corre-
sponds to higher activity (compounds 4, 16  and 28).
The descriptor mol.wt. indicates the presence of a bulky
group at the R1 position, which is detrimental for the
activity. The descriptor bromine count (∼16%) shows
the role of the total number of bromine atoms in a
molecule. It reveals that the presence of an electron-
withdrawing group is favourable for the molecule’s
activity. The plots of predicted vs.  observed values of
pIC50 are shown in Fig. 1c.
pIC50 =  0.7542(±0.1938) SddsN (nitro) count
− 0.1685(±0.0763) MostHydrophobic
+  0.09754(±0.019) SdsCH count
Degrees of Freedom = 24, Ntraining = 26, Ntest = 8,
r2 = 0.7099, q2 = 0.6609, F  test = 20.8543, r2 se = 0.3772,nued)
q2 se = 0.4318, pred r2 = 0.6570, pred r2se = 0.5218,
ZScore Qˆ2 = 1.6542, Best Rand Qˆ2 = 1.1654.
Model (3) explains 70% of the variance in the
observed activity values. The low standard error of
r2 se = 0.3772 demonstrates the accuracy of the model,
and the parameter for the predictivity of the test set
compounds is high, pred r2 = 0.6570, which shows the
external predictive power of the model. The inverse rela-
tionship of this descriptor with the most hydrophobic
group suggests that the presence of a hydrophobic group
on the purine ring can enhance activity. The descriptor
SddsN (nitro) count suggests that increasing the total
number of nitro groups at the R1 position will lead to
improved activity. The descriptor SdsCH count indexes
the total number of CH groups connected with one dou-
ble and one single bond. It shows that the presence of
an aliphatic side chain at the R position of the purine
is favourable for activity. The plots of predicted vs.
observed values of pIC50 are shown in Fig. 1d. The above
models are all validated by predicting the biological
activities of the test molecules, as shown in Table 3.
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Table 3
Observed and predicted activities with residue according to 2D QSAR models.
Com pIC50 2D QSAR model-1 2D QSAR model-2 2D QSAR model-3
Pred. Res. Pred. Res. Pred. Res.
1 5.614 5.569 0.045 5.72 −0.106 5.529 0.085
2 5.616 5.636 −0.02 5.599 0.017 5.667 −0.051
3 5.917 5.862 0.055 5.943 −0.026 5.822 0.095
4 5.928 5.965 −0.037 5.863 0.065 5.869 0.059
5 5.754 5.649 0.105 5.708 0.046 5.622 0.132
6 5.853 5.914 −0.061 5.821 0.032 5.808 0.045
7 6.022 6.173 −0.151 6.14 −0.118 5.941 0.081
8 5.739 5.691 0.048 5.648 0.091 5.631 0.108
9 7.000 7.082 −0.082 7.119 −0.119 6.845 0.155
10 5.657 5.594 0.063 5.579 0.078 5.519 0.138
11 5.978 5.888 0.09 5.917 0.061 5.754 0.224
12 6.124 6.178 −0.054 6.065 0.059 6.019 0.105
13 6.886 6.814 0.072 6.79 0.096 6.797 0.089
14 6.031 6.195 −0.164 5.973 0.058 5.931 0.100
15 6.080 5.993 0.087 5.932 0.148 5.889 0.191
16 6.468 6.307 0.161 6.249 0.219 6.247 0.221
17 6.346 6.215 0.131 6.142 0.204 6.111 0.235
18 6.408 6.252 0.156 6.287 0.121 6.316 0.092
19 6.886 6.75 0.136 6.622 0.264 6.717 0.169
20 7.698 7.583 0.115 7.729 −0.031 7.501 0.197
21 6.920 6.881 0.039 6.825 0.095 6.793 0.127
22 5.696 5.541 0.155 5.765 −0.069 5.569 0.127
23 6.187 6.014 0.173 6.248 −0.061 6.063 0.124
24 5.503 5.435 0.068 5.312 0.191 5.404 0.099
25 5.876 5.799 0.077 5.727 0.149 5.75 0.126
26 5.920 5.896 0.024 2.815 3.105 5.792 0.128
27 5.602 5.579 0.023 5.549 0.053 5.461 0.141
28 6.161 6.113 0.048 6.107 0.054 6.035 0.126
29 6.107 6.154 −0.047 6.062 0.045 6.089 0.018
30 6.468 6.345 0.123 6.251 0.217 6.367 0.101
31 6.585 6.495 0.09 6.673 −0.088 6.363 0.222
32 6.468 6.424 0.044 6.375 0.093 6.288 0.18
3 5.7
3 5.6
4
o
p
f
i
a
i
w
s
t
C
m
c
h
i3 5.913 5.867 0.046 
4 5.798 5.695 0.103 
.  Conclusion
In this investigation, QSAR analysis was performed
n a data set consisting of structurally diverse com-
ounds to investigate the role of their structural
eatures on their c-Src tyrosine kinase inhibitory activ-
ty. The results indicated that the topological, electronic
nd spatial parameters significantly influence activ-
ty. Electron-donating and electron-withdrawing groups
ere found to be an essential feature for c-Src tyro-
ine kinase. The results obtained from this study indicate
he importance of SsCH3E-index, SsOHcount, H-Donor
ount, SsClE-index and SddsN(nitro)count in deter-
ining the binding affinities of purine analogues for
-Src tyrosine kinase. These investigations will further
elp in rationalizing the design of c-Src tyrosine kinase
nhibitors.93 0.12 5.769 0.144
42 0.156 5.667 0.131
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